Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oestrogens and the heart.

G M Rosano1, G Panina

  • 1Department of Cardiology, Istituto H San Raffaele, Rome, Italy.

Therapie
|September 29, 1999
PubMed
Summary

Estrogen replacement therapy significantly reduces cardiovascular disease in postmenopausal women by improving lipid profiles, carbohydrate metabolism, and vascular function. It protects the heart by promoting vasodilation and modulating the neurohormonal system.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Not just numbers, but years of science: putting the ACE inhibitor-ARB meta-analyses into context.

International journal of cardiology·2013
Same author

The DPP-4 inhibitor vildagliptin: robust glycaemic control in type 2 diabetes and beyond.

Diabetes, obesity & metabolism·2007
Same author

Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2007
Same author

Managing cardiovascular risk in menopausal women.

Climacteric : the journal of the International Menopause Society·2006
Same author

[Clinical and diagnostic features of ischemic cardiopathy in women].

Cardiologia (Rome, Italy)·2002
Same author

[Prevalence of heart failure in function of age and relative relevance of current clinical trials].

Cardiologia (Rome, Italy)·2002

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Women's Health

Background:

  • Cardiovascular disease (CVD) incidence is lower in premenopausal women than men, but similar in postmenopausal women.
  • Estrogen deficiency is a primary factor in the increased CVD risk post-menopause.
  • Hormone replacement therapy (HRT) with estrogen shows a significant reduction in CVD events.

Purpose of the Study:

  • To explore the mechanisms behind estrogen's cardioprotective effects in menopausal women.
  • To evaluate the impact of estrogen on various cardiovascular risk factors and pathways.
  • To assess the clinical implications of HRT for preventing and managing CVD in postmenopausal women.

Main Methods:

  • Review of large-scale epidemiological studies on HRT and CVD incidence.
  • Analysis of in vitro and in vivo studies investigating estrogen's effects on lipids, carbohydrate metabolism, and coagulation.
  • Examination of angiographic and human studies assessing coronary artery disease severity in women on HRT.
  • Investigation of estrogen's influence on vascular tone, nitric oxide release, and neurohormonal modulation.

Main Results:

  • Estrogen replacement therapy reduces CVD by approximately 50% compared to untreated women.
  • Estrogens positively influence plasma lipids, carbohydrate metabolism, and coagulation profiles.
  • Estrogens exhibit anti-atherogenic properties, inhibiting plaque formation and reducing arterial occlusion.
  • Estrogens promote vasodilation through endothelium-dependent (nitric oxide) and independent mechanisms.
  • Estrogen therapy modulates the neurohormonal system, reducing sympathetic tone and improving coronary flow reserve.

Conclusions:

  • Estrogen replacement therapy offers significant cardioprotection in postmenopausal women.
  • Multiple mechanisms, including lipid improvement, anti-atherogenic effects, and vasodilation, contribute to estrogen's benefits.
  • HRT should be considered for all menopausal women to prevent or slow the progression of cardiovascular disease.

Related Experiment Videos